AU2001276255A1 - Food supplement - Google Patents
Food supplementInfo
- Publication number
- AU2001276255A1 AU2001276255A1 AU2001276255A AU7625501A AU2001276255A1 AU 2001276255 A1 AU2001276255 A1 AU 2001276255A1 AU 2001276255 A AU2001276255 A AU 2001276255A AU 7625501 A AU7625501 A AU 7625501A AU 2001276255 A1 AU2001276255 A1 AU 2001276255A1
- Authority
- AU
- Australia
- Prior art keywords
- food supplement
- product
- weight
- biosynthesis
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims description 15
- 239000000047 product Substances 0.000 claims description 14
- 239000001062 red colorant Substances 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 241000985513 Penicillium oxalicum Species 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 9
- 230000001093 anti-cancer Effects 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- -1 3-methyl-1,3-butadienyl Chemical group 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 claims description 3
- 230000000069 prophylactic effect Effects 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 description 23
- 235000010633 broth Nutrition 0.000 description 20
- 238000012360 testing method Methods 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 11
- 239000003086 colorant Substances 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 239000002028 Biomass Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 4
- 239000011686 zinc sulphate Substances 0.000 description 4
- 235000009529 zinc sulphate Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000011735 C3H mouse Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 231100000460 acute oral toxicity Toxicity 0.000 description 3
- 239000001132 aluminium potassium sulphate Substances 0.000 description 3
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015946 Eye irritation Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- 231100000490 OECD 405 Acute Eye Irritation/Corrosion Toxicity 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 231100000013 eye irritation Toxicity 0.000 description 2
- 238000000892 gravimetry Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 208000025036 lymphosarcoma Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- CTMLKIKAUFEMLE-FTNGGYTGSA-N (2s)-4-[(e)-2-[(2s)-2-carboxy-6-hydroxy-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydroindol-1-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1N(\C=C\C=1C[C@H](N=C(C=1)C(O)=O)C(O)=O)[C@H](C(O)=O)C2 CTMLKIKAUFEMLE-FTNGGYTGSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- COSQBEPHEWHGJR-UHFFFAOYSA-N 6-[2-(2-hydroxyethylamino)ethyl]indeno[1,2-c]isoquinoline-5,11-dione;hydrochloride Chemical compound Cl.C12=CC=CC=C2C(=O)N(CCNCCO)C2=C1C(=O)C1=CC=CC=C12 COSQBEPHEWHGJR-UHFFFAOYSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 231100000159 OECD 404 Acute Dermal Irritation/Corrosion Toxicity 0.000 description 1
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 229930183845 Secalonic acid Natural products 0.000 description 1
- DRYDKQOPVBDZMQ-UHFFFAOYSA-N Secalonic acid A Natural products COC(=O)C12Oc3ccc(c(O)c3C(=O)C1=C(O)CC(C)C2O)c4ccc5OC6(C(O)C(C)CC(=C6C(=O)c5c4O)O)C(=O)OC DRYDKQOPVBDZMQ-UHFFFAOYSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- KYGRCGGBECLWMH-UHFFFAOYSA-N Sterigmatocystin Natural products COc1cc2OC3C=COC3c2c4Oc5cccc(O)c5C(=O)c14 KYGRCGGBECLWMH-UHFFFAOYSA-N 0.000 description 1
- UTSVPXMQSFGQTM-UHFFFAOYSA-N Sterigmatrocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1C=COC1O1)=C1C=C2OC UTSVPXMQSFGQTM-UHFFFAOYSA-N 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RHGQIWVTIHZRLI-UHFFFAOYSA-N dihydrosterigmatocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1CCOC1O1)=C1C=C2OC RHGQIWVTIHZRLI-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 231100000042 hematotoxic Toxicity 0.000 description 1
- 230000002012 hematotoxic effect Effects 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- NFZJAYYORNVZNI-UHFFFAOYSA-N methyl 4,8,9-trihydroxy-3-methyl-1-oxo-7-(1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5h-xanthen-2-yl)-3,4-dihydro-2h-xanthene-4a-carboxylate Chemical compound OC1C(C)CC(=O)C2=C(O)C3=C(O)C(C4=CC=C5OC6(C(=C(O)C5=C4O)C(=O)CC(C)C6O)C(=O)OC)=CC=C3OC21C(=O)OC NFZJAYYORNVZNI-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 230000003589 nefrotoxic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 1
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- UTSVPXMQSFGQTM-DCXZOGHSSA-N sterigmatocystin Chemical compound O1C2=CC=CC(O)=C2C(=O)C2=C1C([C@@H]1C=CO[C@@H]1O1)=C1C=C2OC UTSVPXMQSFGQTM-DCXZOGHSSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20002950A CZ20002950A3 (cs) | 2000-08-10 | 2000-08-10 | Prostředek s profylaktickým protinádorovým účinkem |
| CZPV2000-2950 | 2000-08-10 | ||
| PCT/CZ2001/000039 WO2002011563A1 (en) | 2000-08-10 | 2001-07-23 | Food supplement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001276255A1 true AU2001276255A1 (en) | 2002-02-18 |
Family
ID=5471599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001276255A Abandoned AU2001276255A1 (en) | 2000-08-10 | 2001-07-23 | Food supplement |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7214713B2 (et) |
| EP (1) | EP1320300B1 (et) |
| JP (1) | JP2004504861A (et) |
| KR (1) | KR20030041970A (et) |
| CN (1) | CN1446053A (et) |
| AP (1) | AP1453A (et) |
| AT (1) | ATE318084T1 (et) |
| AU (1) | AU2001276255A1 (et) |
| BG (1) | BG107615A (et) |
| BR (1) | BR0113121A (et) |
| CA (1) | CA2419066A1 (et) |
| CZ (2) | CZ20002950A3 (et) |
| DE (1) | DE60117388T2 (et) |
| DK (1) | DK1320300T3 (et) |
| EA (1) | EA200300252A1 (et) |
| EE (1) | EE200300057A (et) |
| ES (1) | ES2259036T3 (et) |
| HU (1) | HUP0301241A3 (et) |
| IL (1) | IL154354A0 (et) |
| IS (1) | IS6707A (et) |
| MX (1) | MXPA03001059A (et) |
| NO (1) | NO20030629L (et) |
| NZ (1) | NZ524555A (et) |
| OA (1) | OA12349A (et) |
| PL (1) | PL359845A1 (et) |
| SK (1) | SK285608B6 (et) |
| UA (1) | UA76724C2 (et) |
| WO (1) | WO2002011563A1 (et) |
| YU (1) | YU9803A (et) |
| ZA (1) | ZA200301247B (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004043463A1 (de) * | 2004-06-09 | 2006-02-09 | Heinz Voigt | Mittel zur Krebsbekämpfung unter Verwendung von Schimmelpilzextrakten |
| WO2005121802A1 (de) * | 2004-06-09 | 2005-12-22 | Heinz Voigt | Proteindifferenzierung |
| EP1858519B1 (de) | 2005-03-12 | 2013-02-20 | Bitop Aktiengesellschaft Für Biotechnische Optimierung | Ectoin und/oder hydroxyectoin zur prophylaxe und behandlung chronisch entzündlicher darmerkrankungen |
| DK2262862T3 (da) * | 2007-08-28 | 2012-07-16 | Dtu Technical University Of Denmark | Fremstilling af monascus-lignende azaphilonpigment |
| CZ302696B6 (cs) * | 2009-11-27 | 2011-09-07 | G.E.S. Biomedical S. R. O. | Kmen mikroskopické houby Penicillium oxalicum var. Armeniaca a zpusob výroby cerveného barviva |
| EA028640B1 (ru) * | 2016-06-22 | 2017-12-29 | Сардарян, Гагик Эдуардович | Красный пигмент группы антрахинонов, способ получения красного пигмента штамма гриба penicillium oxalicum var. armeniaca, продукт способа, его применение, фармацевтическая композиция и способ профилактики и/или лечения онкологических заболеваний |
| BR112023000153A2 (pt) * | 2020-07-06 | 2023-03-14 | Chromologics Aps | Método para preparar uma composição de coloração alimentar de atrorosina, sal de atrorosina, pó, composição, laca, tintura, produto, kit e usos |
| CZ309205B6 (cs) * | 2021-02-28 | 2022-05-18 | Gurgen Sardaryan | Způsob výroby směsného pigmentu na bázi červeného, fialového, oranžového a hnědého barviva s antioxidačním účinkem a tento směsný pigmen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264235A (en) * | 1988-07-04 | 1993-11-23 | Campbell Frozen Foods Ltd. | Food product |
| JPH06271561A (ja) * | 1993-03-22 | 1994-09-27 | Taisho Pharmaceut Co Ltd | ジベンゾオキセピン系化合物 |
| US5712306A (en) * | 1995-01-17 | 1998-01-27 | Meiji Seika Kaisha, Ltd. | Physiologically active substances PF1092A, PF1092B and PF1092C, and contraceptives and anticancer drugs containing the same as active ingredients |
| CZ285721B6 (cs) * | 1998-03-30 | 1999-10-13 | Eduard Dr. Sardaryan | Kmen mikroorganismu Penicillium oxalicum var. Armeniaca a jeho použití |
-
2000
- 2000-08-10 CZ CZ20002950A patent/CZ20002950A3/cs not_active IP Right Cessation
-
2001
- 2001-05-22 CZ CZ20011797A patent/CZ289251B6/cs not_active IP Right Cessation
- 2001-07-23 YU YU9803A patent/YU9803A/sh unknown
- 2001-07-23 BR BR0113121-4A patent/BR0113121A/pt not_active IP Right Cessation
- 2001-07-23 JP JP2002516915A patent/JP2004504861A/ja not_active Withdrawn
- 2001-07-23 OA OA1200300021A patent/OA12349A/en unknown
- 2001-07-23 US US10/344,567 patent/US7214713B2/en not_active Expired - Fee Related
- 2001-07-23 DE DE60117388T patent/DE60117388T2/de not_active Expired - Fee Related
- 2001-07-23 PL PL35984501A patent/PL359845A1/xx not_active Application Discontinuation
- 2001-07-23 WO PCT/CZ2001/000039 patent/WO2002011563A1/en active IP Right Grant
- 2001-07-23 EA EA200300252A patent/EA200300252A1/ru unknown
- 2001-07-23 SK SK84-2003A patent/SK285608B6/sk not_active IP Right Cessation
- 2001-07-23 CN CN01813990A patent/CN1446053A/zh active Pending
- 2001-07-23 MX MXPA03001059A patent/MXPA03001059A/es active IP Right Grant
- 2001-07-23 CA CA002419066A patent/CA2419066A1/en not_active Abandoned
- 2001-07-23 EE EEP200300057A patent/EE200300057A/et unknown
- 2001-07-23 ES ES01953765T patent/ES2259036T3/es not_active Expired - Lifetime
- 2001-07-23 AT AT01953765T patent/ATE318084T1/de not_active IP Right Cessation
- 2001-07-23 KR KR10-2003-7001958A patent/KR20030041970A/ko not_active Application Discontinuation
- 2001-07-23 IL IL15435401A patent/IL154354A0/xx not_active IP Right Cessation
- 2001-07-23 AU AU2001276255A patent/AU2001276255A1/en not_active Abandoned
- 2001-07-23 EP EP01953765A patent/EP1320300B1/en not_active Expired - Lifetime
- 2001-07-23 AP APAP/P/2003/002739A patent/AP1453A/en active
- 2001-07-23 NZ NZ524555A patent/NZ524555A/en unknown
- 2001-07-23 DK DK01953765T patent/DK1320300T3/da active
- 2001-07-23 HU HU0301241A patent/HUP0301241A3/hu unknown
- 2001-07-23 UA UA2003032023A patent/UA76724C2/uk unknown
-
2003
- 2003-02-03 IS IS6707A patent/IS6707A/is unknown
- 2003-02-07 NO NO20030629A patent/NO20030629L/no not_active Application Discontinuation
- 2003-02-14 ZA ZA200301247A patent/ZA200301247B/en unknown
- 2003-03-06 BG BG107615A patent/BG107615A/bg unknown
-
2006
- 2006-04-14 US US11/405,000 patent/US20060247316A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060247316A1 (en) | Food supplement | |
| US6197295B1 (en) | Dietary supplementation with, and methods for administration of yeast-derived selenium product | |
| EP1478732B1 (en) | A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug | |
| US20110052732A1 (en) | Mineral absorption accelerator and iron deficiency anemia improver of food composition | |
| EP0242459B1 (en) | Use of oligosaccharides for promoting the proliferation of bifidobacteria | |
| US5470827A (en) | Method of producing iturin A and antifungal agent for profound mycosis | |
| US6248323B1 (en) | Dietary supplementation with and methods for preparation of yeast-derived chromium salts | |
| KR0140057B1 (ko) | 식물엑기스 발효액을 함유한 알코올 대사성음료 및 그의 제조방법 | |
| US20030096029A1 (en) | Remedies for allergic diseases and process for producing the same | |
| US20030219456A1 (en) | Method of utilization of zygosaccharomyces rouxii | |
| CZ2009795A3 (cs) | Kmen mikroskopické houby Penicillium oxalicum var. Armeniaca, zpusob jeho kultivace a využití | |
| WO1998037172A1 (en) | Dietary supplementation with, and methods for preparation of yeast-derived selenium salts | |
| KR101400967B1 (ko) | 에리소르빌 라우레이트를 유효성분으로 함유하는 것을 특징으로 하는 항균용 조성물 및 이의 용도 | |
| SE461101B (sv) | Anvaendning av stammar fraan gruppen bacillus foer utvinning av sackarasinhibitorer samt saett att framstaella sackarasinhibitorer | |
| JPS6126969B2 (et) | ||
| NO853460L (no) | Nye pseudooligosakkarider med alfa-glukosidasehemmende virkning, fremgangsmaate til deres fremstilling og deres anvendelse samt farmasoeytiske preparater. | |
| RU2117486C1 (ru) | Лечебно-профилактический антианемийный и иммунокоррегирующий дрожжевой препарат | |
| JPH04287693A (ja) | ε−ポリリジンの製造方法 | |
| CN116874624A (zh) | 一种胶状鳞伞菌多糖的制备方法及应用 | |
| EP0800400A1 (en) | Germanium yeast human diet nutritional supplement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |